Life Sciences

Healthcare

insitro to Acquire CombinAbleAI, Unlocking a Full-Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

insitro, the AI therapeutics company built on causal biology, announced that it has entered into a definitive agreement to acquire CombinAbleAI and launch its...

Healthcare

Anthropic Unveils Expanded Claude Capabilities for Healthcare and Life Sciences

Anthropic announced a major expansion to its Claude platform, adding Claude for Healthcare to its existing expanded capabilities in Claude for Life Sciences. These...

Healthcare

Revvity and Lilly Partner to Broaden AI Drug Discovery

Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering Revvity, Inc. announced a collaboration with Eli Lilly and Company (Lilly) that...

Healthcare

L7 Informatics and Turnberry Team Up to Advance Life Sciences

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster-from strategy to measurable outcomes. L7 Informatics, and Turnberry...

Healthcare

GeneDx Names Dr. Linda Genen as Chief Medical Officer

Recognized neonatologist and payer-strategy leader joins GeneDx to expand earlier diagnosis and establish genomics as a standard of care across healthcare GeneDx has officially appointed Dr....

Healthcare

Matrix One Expands Life Sciences Software With Simploud Deal

In its third major move in six months, Matrix One (backed by Lauxera Capital Partners) has acquired Simploud, a cloud-native provider of Quality Management...

Healthcare

Insilico Medicine and Servier Forge Up to US$888 Million Multi-Year Oncology R&D Collaboration

Fresh off its landmark December 2025 listing on the Hong Kong Stock Exchange, Insilico Medicine has inked a multi-year R&D collaboration with global pharma...

Healthcare

Edison Scientific Secures $70M Seed Funding to Accelerate AI-Driven Scientific Discovery

Edison Scientific has announced a successful $70 million seed funding round led by Triatomic Capital, Spark Capital, and a major US institutional biotech investor,...

Life Sciences

Lunit and Daiichi Sankyo Partner to Accelerate AI-Driven Biomarker Discovery in Oncology

Lunit Partnering with Daiichi Sankyo to Bring AI-Powered Pathology Analysis into Two of Daiichi Sankyo’s Oncology Research and Development Programs to Facilitate Faster Biomarker...

Healthcare

Accenture Backs Ryght AI to Transform Clinical Research

Accenture has invested in Ryght AI, a platform provider that modernizes how clinical research is designed and executed for the life sciences industry. This...